HomeCompareOTSKF vs JNJ

OTSKF vs JNJ: Dividend Comparison 2026

OTSKF yields 1.29% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OTSKF wins by $44.00 in total portfolio value
10 years
OTSKF
OTSKF
● Live price
1.29%
Share price
$70.34
Annual div
$0.91
5Y div CAGR
30.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$2,626.27
Full OTSKF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — OTSKF vs JNJ

📍 OTSKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOTSKFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OTSKF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OTSKF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OTSKF
Annual income on $10K today (after 15% tax)
$109.97/yr
After 10yr DRIP, annual income (after tax)
$2,232.33/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $1,805.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OTSKF + JNJ for your $10,000?

OTSKF: 50%JNJ: 50%
100% JNJ50/50100% OTSKF
Portfolio after 10yr
$30.5K
Annual income
$3,688.07/yr
Blended yield
12.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OTSKF
No analyst data
Altman Z
5.2
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OTSKF buys
0
JNJ buys
0
No recent congressional trades found for OTSKF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOTSKFJNJ
Forward yield1.29%2.14%
Annual dividend / share$0.91$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR30.5%28%
Portfolio after 10y$30.5K$30.5K
Annual income after 10y$2,626.27$4,749.88
Total dividends collected$9.2K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OTSKF vs JNJ ($10,000, DRIP)

YearOTSKF PortfolioOTSKF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,869$168.83$10,594$274.49+$275.00OTSKF
2$11,853$223.80$11,294$360.69+$559.00OTSKF
3$12,981$297.68$12,133$476.91+$848.00OTSKF
4$14,287$397.59$13,156$635.42+$1.1KOTSKF
5$15,821$533.70$14,432$854.61+$1.4KOTSKF
6$17,649$720.80$16,056$1,162.76+$1.6KOTSKF
7$19,865$980.70$18,175$1,604.53+$1.7KOTSKF
8$22,602$1,346.27$21,009$2,252.68+$1.6KOTSKF
9$26,052$1,868.16$24,911$3,229.73+$1.1KOTSKF
10$30,502$2,626.27$30,458$4,749.88+$44.00OTSKF

OTSKF vs JNJ: Complete Analysis 2026

OTSKFStock

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a conditioning beverage; EQUELLE and EQUELLE Gelée, which supports women's health and beauty; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; and OS-1, an oral rehydration solution. In addition, the company offers soft drinks, food products, and wines; clinical testing and medical equipment; cosmetics; warehousing and transport services; chemical products; travel agency services; analysis and measurement equipment; pharmaceutical intermediates; testing equipment, such as vehicle headlight testers; synthetic resin molded products; venture capital services; paper products; artificial turf; ceramic boards, ceramic board masterpiece arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; IT solution services; insecticides and toiletry products; and flaky titanate and special compounds. Further, it provides infusion and clinical nutrition products; Xenotransplantation products; hydrazine; plant-based food products, including cheese alternatives, dressings, and desserts; stable isotopes; software and services to enhance management of mental healthcare systems; products for urinary tract health; potassium titanate; bio-pesticides; functional and dietetic foods; spring and mineral water; industrial chemicals; polyolefin foams; anticancer drugs; and adhesive tapes. Additionally, the company operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

Full OTSKF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this OTSKF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OTSKF vs SCHDOTSKF vs JEPIOTSKF vs OOTSKF vs KOOTSKF vs MAINOTSKF vs ABBVOTSKF vs MRKOTSKF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.